Research Priorities to Accelerate Global Uptake of Lower Sodium Salt Substitutes
BACKGROUND: Excess sodium intake is a modifiable cause of elevated blood pressure and cardiovascular disease. Despite the World Health Organization's recommendation to limit sodium intake <2 g/d, average global consumption exceeds twice this amount. Replacing a portion of sodium chloride with potassium chloride in lower sodium salt substitutes lowers blood pressure and cardiovascular disease risk. Further research will support global scale up. METHODS: We convened 5 international webinars to identify and prioritize research needs to advance global adoption of lower sodium salt substitutes, focusing on 4 domains: safety/efficacy, industry/food technology, implementation, and public policy. Survey data and qualitative feedback were synthesized into a consolidated research agenda. RESULTS: The top identified research priorities were, safety/efficacy: assessing safety among at-risk individuals, defining clinical significance of modest hyperkalemia, and evaluating long-term effects on cardiovascular disease, kidney function, and age-related blood pressure rise; industry/food technology: testing consumer acceptability, assessing functional performance in processed foods, and determining optimal formulations; implementation: determining how to increase stakeholder engagement, improve labeling and messaging, and identify behavioral-economic approaches to encourage lower sodium salt substitutes adoption without increasing sodium intake; public policy: evaluating the potential cost-effectiveness of subsidies, tariff reductions, procurement mandates, and integration with iodization programs, as well as assessing which implementation contexts are best suited to mandatory versus voluntary approaches. CONCLUSIONS: The research priority agenda underscores the substantial opportunity for lower sodium salt substitutes to serve as a transformative, scalable intervention for global cardiovascular disease prevention. Targeted safety/efficacy studies, strategies to ensure consumer receptiveness, cost optimization, and enabling policy frameworks are next steps for widespread implementation.
Authors
- Kathy Trieu (ORCID: https://orcid.org/0000-0003-1848-2741)
- J. Jaime Miranda (ORCID: https://orcid.org/0000-0002-4738-5468)
- Mary‐Anne Land (ORCID: https://orcid.org/0000-0002-7807-2886)
- Lawrence J. Appel (ORCID: https://orcid.org/0000-0002-0673-6823)
- Penjani Mkambula
- Martijn W. J. Noort (ORCID: https://orcid.org/0000-0003-3655-4796)
- Tammy McLoughlin Brady (ORCID: https://orcid.org/0000-0002-1315-6747)
- Tazeen H. Jafar (ORCID: https://orcid.org/0000-0001-7454-8376)
- Laura K. Cobb
Institutions
- The University of Sydney (AU)
- Children's National (US)
- George Washington University (US)
- Global Alliance for Improved Nutrition (CH)
- The George Institute for Global Health (AU)
- Duke-NUS Medical School (SG)
- Wageningen University & Research (NL)
Publication Details
- Journal
- Hypertension
- Published
- 2026-09-24
- DOI
- https://doi.org/10.1161/hypertensionaha.126.27540
- Primary Topic
- Sodium Intake and Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00